Drugs / budesonide/formoterol
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00496470 Comparator | May 2007 → Jun 2008 | chronic obstructive pulmonary disease | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | budesonide/formoterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00496470 ↗ |
| Known as | BUD/FORM | “Assess the cost effectiveness of budesonide/formoterol (BUD/FORM) Turbuhaler(®)+tiotropium (TIO) HandiHaler(®) vs. placebo (PBO)+TIO in patients with chronic obstructive...” PMID 23856511 ↗ Jul 2013 |
| Route | Inhaled | “Symbicort Turbuhaler® (budesonide/formoterol) 320/9 mcg, one inhalation twice daily” NCT00496470 ↗ |